Skip to main content
logo
Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
83.68
+0.64 (0.77%)
At close: Jul 28, 2026, 4:00 PM EDT
83.00
-0.68 (-0.81%)
After-hours: Jul 28, 2026, 7:14 PM EDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20 Sep '20
Transcatheter Aortic Valve Replacement Revenue
1.26B
Transcatheter Mitral and Tricuspid Therapies Revenue
198.60M
Surgical Structural Heart Revenue
284.10M
Revenue (Total)
1.74B

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20 Sep '20
United States Revenue
1.00B
Europe Revenue
439.60M
Japan Revenue
96.40M
Rest of World Revenue
201.50M
Revenue (Total)
1.74B